- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Mr Mfazo Hove
- Published: June 18, 2025
- Last Updated: August 18, 2026
TL;DR: In London, Convenience Should Not Choose Your ICL Provider
If you live in London or the Home Counties, some of the deepest concentrations of refractive expertise in the country are already within your reach, which means convenience of the journey should usually carry far less weight in your decision than the surgeon and the clinical system, even though for some patients mobility, health or support needs can make travel a genuine consideration. This page makes the geography argument properly: the wrong way to use it, the right way, what is actually worth travelling for, and how the Blue Fin Vision® network resolves the tension. The full provider test, including the Year-20 Test, is in Best Place to Get ICL Surgery in London?
An Implantable Collamer Lens (ICL) stays inside your eye for decades. The journey home takes an hour. Those two things should not carry equal weight.
Here is the fact that should shape your entire choice of provider: an ICL is not an event. It is a decades-long relationship. The lens sits inside your eye, in front of your natural lens, and it needs to be respected for as long as it is there: the vault, the space between ICL and natural lens, should be checked, and your corneal endothelial cell count monitored over the years. ¹ And if, in later life, your natural lens develops a cataract, the ICL is removed as part of the transition to cataract surgery and an intraocular lens. Providers differ substantially in what happens after routine postoperative follow-up: ask specifically what monitoring is offered after year one, how long it continues and whether it is included in the original fee. The Blue Fin Vision® pathway is designed for the entire life of the lens.
The Wrong Way to Use Geography
The wrong way is to start with “Who is nearest?” and let visibility finish the job. The parts of ICL care that determine your decades are exactly the parts a proximity decision never examines, and with an ICL the differences do not show up in week one; they surface in year five, year ten and year twenty, when the question is who is still measuring your eye.
The Right Way to Use Geography
The right way is to ask a different question: “Which excellent clinical system can make my long-term follow-up convenient?” Choose the surgeon and the system first, on evidence. Then, and only then, let geography optimise the part of the pathway where it genuinely helps: the visits that repeat for decades.
What Is Actually Worth Travelling For
Do not travel farther merely because somebody calls themselves better. Travel farther, if you need to, for the clinical differences that can justify it. There are eight.
Surgeon expertise, evidenced. ICL-specific research shows that preoperative anatomy, selected ICL size and implantation orientation materially influence postoperative vault prediction. ² A surgeon whose current ICL volumes, audit culture and removal capability are on the record is worth a longer journey than a nearer name without them.
Sizing and vault judgement. Sizing and the resulting postoperative vault are among the most important technical considerations in the entire procedure, and the difference between a provider that predicts, measures and follows your vault and one that does not will matter for decades. Long-term follow-up shows vault can change gradually over the years, ¹ so this is a travelling-for difference, not a nicety.
A recorded endothelial baseline. The endothelium has very limited regenerative capacity in vivo. A provider that records your baseline cell count before surgery has given every future measurement a meaning; a provider that does not has quietly disabled your year-ten monitoring before it began.
Toric planning. If you have astigmatism, the axis planning, placement precision and repositioning pathway around a toric ICL are surgeon-level skills worth seeking out.
Genuine alternatives. A practice that offers only ICL has fewer alternative refractive pathways available when ICL is not the best solution. A system spanning ICL, laser and lens replacement can let the recommendation follow your eye, and that honesty is worth a journey.
Written enhancement terms. Provider policies vary: enhancement may be included for a defined period, subject to eligibility, charged separately or handled under provider-specific terms. A written 24-month policy you can read before paying is a concrete, comparable difference.
Removal and exchange capability. Exchange is uncommon, 1.1% in a recent 961-eye high-volume series, ³ but the rare patient who needs it should not discover their provider cannot do it. In-house repositioning, exchange and removal is a structural difference between systems.
Lifetime surveillance. Structured vault and endothelial monitoring at defined intervals, under a framework like the Lifetime Monitoring Protocol™, is the difference between a provider whose relationship ends at the final review and one built for the life of the lens.
London Versus the Home Counties
For much of Greater London and the surrounding Home Counties, many of London’s leading refractive centres are within a manageable journey, often around an hour to ninety minutes, depending on location and traffic. A patient in Hatfield, Chelmsford or Mill Hill should therefore not automatically accept the nearest unrelated provider simply because central London looks inconvenient, because the inconvenience is smaller than it appears and, with the right system, mostly temporary: the journeys that recur can be local ones.
Five Journeys Versus Twenty Years
Do the arithmetic properly. The front-loaded part of ICL care is a handful of journeys: an assessment, surgery, and the early reviews, perhaps five or six trips spread over months. Every one of those journeys ends. The lens does not. Weigh five journeys against twenty years of living with the judgement, sizing and surveillance of whoever you chose, and the convenience argument collapses under its own proportions. Optimising the five journeys at the cost of the twenty years is the trade nobody would make if they saw it written down.
Choosing the Best Place to Get ICL Surgery in London
Choosing the best place to get ICL surgery in London means selecting quality first and making recurring care local second. Blue Fin Vision® operates one clinical system across London and the Home Counties, at the Harley Street Eye Centre, Weymouth Street Hospital, Chase Lodge Hospital in Mill Hill, One Hatfield Hospital and Phoenix Hospital Chelmsford. Assessments and long-term ICL monitoring under the Lifetime Monitoring Protocol™ can be provided across the network, with surgery at our surgical centres confirmed for your case at consultation. So the decades of monitoring that matter most can happen close to home, without the location choosing your surgeon. Geography can be made convenient without being allowed to make the decision.
The system behind all of this is published: the Blue Fin Vision® Advantage, the Enhancement Policy, the ICL Surgery Checklist to test any provider against, including us, and transparent pricing on the ICL costs page.
It ends. The lens in your eye does not, until the day it is planned to.
Book a consultation at whichever of our clinics suits you best to discuss your ICL suitability with a consultant-led UK clinic offering documented outcomes and structured long-term monitoring.
References
- Alfonso-Bartolozzi B, Fernández-Vega-Cueto L, Lisa C, Palacios A, Madrid-Costa D, Alfonso JF. Ten-year follow-up of posterior chamber phakic intraocular lens with central port design in patients with low and normal vault. J Cataract Refract Surg. 2024;50(5):441-447. doi:10.1097/j.jcrs.0000000000001379. PMID: 38085219.
- Yang Y, Long Z, Lei B, Liu W, Ye J. Clinical decision support system based on deep learning for evaluating implantable collamer lens size and vault after implantable collamer lens surgery: a retrospective study. BMJ Open. 2024;14(2):e081050. doi:10.1136/bmjopen-2023-081050. PMID: 38365302.
- Hirabayashi M, Virdi G, Nasser T, Libfraind L, Zapata EA, Abramson AJ, Parkhurst G. ICL exchanges or explants due to sizing in a United States high volume center. Clin Ophthalmol. 2025;19:2609-2614. doi:10.2147/OPTH.S528280. PMID: 40800717.
ABOUT THE AUTHOR
Mr Mfazo Hove
Consultant Ophthalmic Surgeon
MBChB MD FRCOphth CertLRS
Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with experience spanning more than 57,000 procedures. He completed 6.5 years of specialist training at Moorfields Eye Hospital and served for five years as a consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust. He is the founder of Blue Fin Vision®, a consultant-led private ophthalmology practice operating across London, Essex, and Hertfordshire. His clinical expertise encompasses advanced cataract surgery, refractive lens replacement, laser vision correction, and implantable Collamer lenses (ICL).
A ZEISS Key Opinion Leader, Mr Hove is a respected international speaker with five invited engagements across seven cities in 2026:
- ZEISS China tour (Changsha, Shanghai, and Hangzhou, April – ZEISS APAC User Meeting)
- RCOphth Annual Congress – May – Manchester
- ZEISS EMEA User Meeting (Istanbul)
- ZEISS Lausanne User Meeting (Lausanne)
- European Society of Cataract and Refractive Surgeons Annual Congress (ESCRS, London)
